Catalyst Tracker
05/08/2024 04:49 PM ET
NanoViricides PRME date announcement
Prime Medicine plans to announce top-line results for their IND-Enabling trial of PM359 on May 7, 2025. Currently, this drug has a 69% chance of progressing.
The announcement didn’t do the company's stock any [...]
Read More
05/08/2024 04:49 PM ET
Cytokinetics Incorporated CYTK results announcement
Cytokinetics Incorporated released new information about their Phase 3 trial for Aficamten - (CEDAR-HCM). The results are summarized below:
"Phase 3 initiated, noted May 8, 2024."
Cytokinetics Incorporated edged down $0.01 (-0.02%) to $65.27 on [...]
Read More
05/08/2024 04:49 PM ET
Seres Therapeutics CRSP results announcement
CRISPR Therapeutics AG, makers of CTX450, have released new information on its trial. The results were summarized as follows:
"IND/CTA-enabling studies planned for 2H 2025."
The market didn’t take the news well, unfortunately. CRISPR [...]
Read More
05/08/2024 04:49 PM ET
ArriVent BioPharma AVBP earnings announcement
ArriVent BioPharma revealed their most recent quarterly earnings data, in which EPS ended up higher than estimates. EPS was estimated to be -$1.05 and the actual figure came in at -$0.70.
Closing price inched up [...]
Read More
05/08/2024 04:49 PM ET
Seres Therapeutics INDP earnings announcement
Indaptus Therapeutics revealed their most recent quarterly earnings data for Q1. EPS was reported to be -$0.45, which fell in line with the estimated value of -$0.44. Indaptus Therapeutics' EPS is now up [...]
Read More
05/08/2024 04:49 PM ET
NanoViricides KROS earnings announcement
Keros Therapeutics revealed their most recent quarterly earnings data, in which EPS ended up higher than estimates. Revenue was reported to be $83k and EPS was -$1.21. For EPS, that is the highest it has [...]
Read More
05/08/2024 04:49 PM ET
Aadi Bioscience AADI earnings announcement
Aadi Bioscience revealed their most recent quarterly earnings data, in which both revenue and EPS ended up lower than estimates. EPS was estimated to be -$0.64, but the actual figure came in at -$0.68. [...]
Read More
05/08/2024 04:49 PM ET
Seres Therapeutics VCEL earnings announcement
Vericel Corporation beat their EPS estimate and fell in line with their revenue estimate, according to their recent quarterly earnings data. Revenue was reported to be $51.28M and EPS was -$0.08. Vericel [...]
Read More
05/08/2024 04:49 PM ET
NanoViricides KPTI earnings announcement
Karyopharm Therapeutics revealed their most recent quarterly earnings data for Q1. Revenue was $33.13M, missing estimates by 3.9%. Karyopharm Therapeutics' revenue is now down $5.57M (-14.4%) over the past year.
The market didn’t take [...]
Read More
05/08/2024 04:48 PM ET
Syndax Pharmaceuticals SNDX earnings announcement
Syndax Pharmaceuticals revealed their most recent quarterly earnings data, in which EPS ended up higher than estimates. EPS was reported to be -$0.85, which beat the estimated value of -$0.98.
Despite the good [...]
Read More
05/08/2024 04:48 PM ET
Seres Therapeutics EDIT earnings announcement
Editas Medicine revealed their most recent quarterly earnings data, in which both revenue and EPS ended up lower than estimates. EPS was estimated to be -$0.67, but the actual figure came in at -$0.76. [...]
Read More
